Qlaris Bio, Inc. funding
Qlaris Bio, Inc., a biotechnology company based in Dedham, MA, filed a Form D with the SEC on June 17, 2026 and reported $3.9M raised. It filed 2 new offerings in this period, totaling $9.6M.
Amount raised$3.9M
Offering size$3.9M
Filed with the SECJune 17, 2026
First saleJune 12, 2026
IndustryBiotechnology
SecuritiesDebt, Options or warrants, Other
LocationDedham, MA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far8
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jun 17
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| June 17, 2026 | $3.9M | $3.9M | Debt, Options or warrants, Other |
| November 17, 2025 | $5.6M | $5.6M | Debt, Options or warrants, Other |
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$22.8M · Sep 16Other Health CareXact Bio, Inc.$10M · Sep 28BiotechnologyCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care